Anzeige
Mehr »
Login
Donnerstag, 02.05.2024 Börsentäglich über 12.000 News von 685 internationalen Medien
"Special Situation"-Aktie mit Multi-Tenbagger-Potenzial im heißesten Rohstoff-Markt
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
84 Leser
Artikel bewerten:
(0)

Sunquest Information Systems Acquires UNIConnect L.C.


Acquisition expands Sunquest's solution for molecular pathology laboratories and advances precision medicine initiative

TUCSON, Arizona and SALT LAKE CITY, Nov. 10, 2016 /PRNewswire/ -- Sunquest Information Systems, Inc. announced today the acquisition of the Salt Lake City-based software firm UNIConnect® L.C. UNIConnect specializes in software for molecular laboratories and augments Sunquest's molecular diagnostics solution.

"With the acquisition of UNIConnect, Sunquest is now able to deliver an end-to-end solution for molecular and genetic testing," said Matthew Hawkins, president of Sunquest. "The addition of UNIConnect's innovative technology aligns with one of our top priorities: delivering precision medicine solutions that advance patient care."

UNIConnect is a global provider of advanced process management software that helps molecular laboratories meet their most complex clinical challenges. The acquisition of UNIConnect augments Sunquest's April 1, 2016 purchase of GeneInsight, a genetics informatics solution that streamlines the analysis, interpretation and reporting of complex genetic tests.

"While working with our mutual customer MedComp Sciences, we realized that the integration of GeneInsight and UNIConnect's process management software created tremendous workflow efficiencies for molecular pathology laboratories," said Chris Callahan, general manager of GeneInsight, a Sunquest company. "We look forward to offering other labs our fully integrated solution, which provides a complete molecular and genetics platform that significantly reduces the barrier of entry for labs seeking to offer cutting-edge molecular diagnostic tests."

The integration of UNIConnect and GeneInsight provides the molecular diagnostics community with a complete molecular and genetics platform that manages workflow from instrument to EMR, including sample management, bioinformatics, analysis and report management. The combination of workflow automation technology and tools for streamlining the analysis, interpretation and reporting of complex genetic tests will help make the promise of precision medicine a practical reality.

"New sequencing technologies have made personal genetic information much more accessible, but the management of such large amounts of information is challenging," said Jason Walker PhD MT(AAB), lead geneticist/technical supervisor for MedCompGx, LL. "By integrating our UNIConnect platform with GeneInsight, we are able to deploy next-generation sequencing for clinical diagnostics. Patient data and NGS results now move easily and intuitively between the platforms. The fit could not have been better and the integration works beautifully."

"We are both proud and excited to join Sunquest and extend our contribution in the realms of molecular laboratory automation and process management," said William S. Harten, UNIConnect founder and CEO. "By working together, we'll be able deliver a complete automation solution that helps more molecular labs manage their increasingly large and complex workloads and advances the exciting realm of precision medicine."

About UNIConnect
Based in Salt Lake City, UT, UNIConnect® L.C. has created a LIMS platform that marries breakthrough software technology with unparalleled customization and configuration control to advance the "omic" sciences and precision medicine. With a corporate ideal of "rigorous simplicity," UNIConnect's pMDx' software solution enables complex process tracking, eliminating information management barriers that slow progress for many life science laboratories. For the exacting process detail required for precision medicine, molecular diagnostics, proteomics, clinical trials and more, pMDx delivers best-of-class solutions that empower successful laboratory operations. For more information, see www.uniconnect.com.

About GeneInsight
GeneInsight, a Sunquest company, provides a molecular informatics solution that streamlines the analysis, interpretation and reporting of complex genetic tests. In constant clinical use since 2005, GeneInsight facilitates delivery of test results to treating clinicians so they can integrate genetics into their routine diagnostic workflows. The hosted solution includes filtration, annotation and storage tools, along with novel variant assessment, variant knowledge management and reporting capabilities.GeneInsight is a wholly owned subsidiary of Sunquest Information Systems, a pioneer in laboratory informatics.

About Sunquest Information Systems
Sunquest Information Systems Inc. provides diagnostics informatics solutions to more than 1,700 laboratories. Since 1979, Sunquest has helped laboratories and healthcare organizations across the world optimize financial results, enhance efficiency and improve the quality of patient care. The company's singular focus on diagnostic innovation has delivered solutions that offer unique support for complex testing, enable community-wide connectivity and can be used at the point-of-care. Headquartered in Tucson, AZ with offices in the United Kingdom, United Arab Emirates and India, Sunquest is a global leader in healthcare information technology. For more information, visit www.sunquestinfo.com.

Contact: Stephanie Clohessy, 520-570-2599, stephanie.clohessy@sunquestinfo.com




Kupfer - Jetzt! So gelingt der Einstieg in den Rohstoff-Trend!
In diesem kostenfreien Report schaut sich Carsten Stork den Kupfer-Trend im Detail an und gibt konkrete Produkte zum Einstieg an die Hand.
Hier klicken
© 2016 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.